In addition, 1 year post-GBS serum profiles exhibited a significant reduction of total blood cholesterol, LDL cholesterol (LDL-c), fasting insulin and leptin levels, as well as levels of several inflammatory biomarkers (Table S1). This evidence concerns the gene INS and Guillain-Barre syndrome.